News Shire plans filing for HAE drug after phase 3 success Lanadelumab could revolutionise treatment of swelling disease.
News CEO Meek looks to boost Ipsen with drug acquisitions Could French biotech snap up remaining rights to pancreatic cancer drug?
News Novartis takes option on NASH drug from Conatus Swiss pharma takes option on FXR agonist emricasan.
News PatientsLikeMe and Shire to co-develop rare disease patient ... Data from the new platform will help inform rare disease drug development.
News Novartis takes aim at Shire and Allergan with dry-eye drug Swiss company takes option on Lubris' ECF843.
News Alexion appoints former Baxalta chief Hantson as CEO Former AZ chief David Brennan expected to take over as chairman in May.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
